Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

afsha - infections > influenza > Flashcards

influenza Flashcards

1
Q

how many types

A

3: A, B, C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

which type if more virulent and occurs more frequently

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

which type presents a milder course of disease but still has potential to cause outbreaks

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

which type causes mild or asymptomatic disease, similar to the common cold

A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

which types can be further categorised into subtypes depending on their principle H and N antigens?

A

A and B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

transmission occurs via

A

droplets, aerosols, or direct contact with respiratory secretions from an infected person

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

usual incubation period

A

1-3 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what does incubation period mean

A

the period between exposure to an infection and the appearance of the first symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

symptoms usually appear suddenly or take a while?

A

suddenly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

symptoms include…

A

chills
fever
headache
extreme fatigue
myalgia
dry cough
sore throat
nasal congestion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

complications - respiratory and non-respiratory

A
  • usually respiratory in nature and may include bronchitis, secondary bacterial pneumonia or otitis media (in children)
  • non-respiratory complications rarer and may be cardiac or neurological in nature
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

influenza is usually self limiting with recovery occurring within how many days?

A

2-7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

classifications of influenza (not types!)

A

uncomplicated
complicated (either needing hospitalisation, having signs or symptoms of LRTI, CNS involvement or exacerbation of an underlying condition)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

risk of more serious illness is greater for those in at risk groups….

A

children under 6 months
pregnant females, including females up to 2 weeks PP
adults over 65
pt with long term conditions e..g respiratory, renal, hepatic, neurological or cardiac disease, DM or morbid obesity (BMI ≥ 40 kg/m²), or those with severe immunosuppression)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

patients with this BMI are at risk of more serious illness

A

BMI ≥ 40 kg/m² - morbid obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

which two antivirals are used for both treatment and post exposure prophylaxis of influenza?

A

oseltamivir and zanamivir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

oseltamivir and zanamivir are used for both treatment and post exposure prophylaxis of influenza. there is evidence that some strains of influenza are more likely to develop resistance to which one of these?

A

oseltamivir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

the risk of developing oseltamivir resistance is considered to be greater for which type ?

A

A , risk if higher in pt who are severely immunocompromised

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

the risk of developing oseltamivir resistance is higher in which set of pt

A

severely immunocompromised

20
Q

can you give amantadine HCl for treatment or post exposure prophylaxis of influenza A

A

No not recommended

21
Q

treatment of suspected or confirmed influenza - when treatment with oseltamivir is indicated, it should be started…

A

ASAP ideally within 48 hours of symptom onset

22
Q

for treatment of suspected or confirmed influenza, when treatment with oseltamivir is indicated, it should be started ASAP ideally within 48 hours of symptom onset. can be be started later than this ?

A

treatment initiation beyond 48h onset is unlicensed and clinical judgement should be used
there is evidence to suggest the risk of mortality may be reduced even if treatment is started up to 5 days after symptom onset

23
Q

treatment if suspected or confirmed influenza - where treatment with inhaled zanamivir is indicated, it should be started…

A

ASAP ideally within 48 hours (36 hours in children) of symptom onset
treatment initiation beyond this time is unlicensed and clinical judgement should be used

24
Q

treatment if suspected or confirmed influenza - where treatment with IV zanamvir is indicated , it should be started

A

ASAP and within 6 days of symptom onset

25
Q

for those with uncomplicated influenza but considered to be at serious risk of developing complications, offer this antiviral drug

A

oseltamivir

26
Q

for patients in at risk group (including pregnant🤰but excluding severely immunocompromised), offer this antiviral and do not wait for lab test results to treat

A

oseltamivir

27
Q

when would a pregnant female be given zanamivir first line?

A

meets additional criteria
treamtent should be discussed with a local infection specialist

28
Q

what to do when you are considering treatment for severely imunocompromised paeople + which treatment to offer

A

consider the subtype of influenza causing infection, or if not yet know, take into account the current dominant circulating strain
1st line oseltamivir unless strain has higher risk of resistance, in which case offer inhaled zanamivir
if unable to use inhaled due to underlying severe resp disease or inability to use device (including under 5), offer oseltamivir and assess repsonse to therapy

29
Q

for patients with uncomplicated influenza who require treatment due to being at serious risk of devleoping complications etc and they have suspected or confirmed oseltamivir resistant influenza, offer …

A

inhaled zanamivir
if unable to use this, consider IV (unlicensed)

30
Q

what to do with pt who have complicated flu

A

all pt should be tested and treated
often in hospital
do not wait for lab results to treat

31
Q

treatment of complicated flu for pt where there is risk of reduced GI absoprtion, or if inital oseltamivir unsuccessful

A

inhaled zanamivir

31
Q

treatment of complicated flu for pt who are not severely immunosuppressed

A

1st line oseltamivir

32
Q

who should be offered post exposure prophylaxis following exposure to a person in the same household or residential setting with influenza like illness (when influenza is circulating)?

A

contacts in at risk group who arent adequately protected through vaccination (e.g. due to infection by different circulating strain or exposure within 14 days post vaccination)

33
Q

when does flu vaccine start giving you protection

A

after 14 days

33
Q

who may be considered for antiviral prophylaxis post-exposure regardless of vax status?

A

certain populations that are susceptible to localised outbreaks e..g care homes, prisons, detention centres

33
Q

when is oseltamivir given 1st line regardless of risk of resistance of circulating or index strain

A

when its used for post exposure prophylaxis in pt in at risk group (including pregnant, but excluding severely immunocompromised

33
Q

what are the treatment options available for post exposure prophylaxis and when should they be started

A

prophylaxis should be started ASAP following exposure
ideally within 48h for oseltamivir
ideally within 36h for inhaled zanamivir
initation beyond these times is unlicnesed, seek specialist advoce

33
Q

1st line for post exposure prophylaxis for pt in at risk group (incl pregnant females, EXCL severely immunosuppressed and children under 5)

A

oseltamivir regardless of risk for resistance of the circulating or index case strain

34
Q

post exposure prophylaxis for pt exposed to a strain with suspected or confirmed oseltamivir resistance

A

inhaled zanamivir

35
Q

treatment post exposure prophylaxis for severely immunosuppressed pt EXCL under 5

A

oseltamivir if risk for resistance is low
if risk for resistance is high, suspected or confirmed, offer inhaled zanamivir

36
Q

post exposure prophylaxis treatment for pt at higher risk of oseltamivir resistance who are unable to used inhaled zanamivir (due to underlying severe respiratory disease or unable to use device)

A

oseltamivir and advice pt to seek immediate medical attention if symptoms develop subsequently

37
Q

post exposure prophylaxis treatment for pt who are exposed to suspected or confirmed oseltamivir resistance influenza who are unable to use inhaled zanamivir

A

seek specialist advice
monitor pt closely for influenza like illness
arrangements made for prompt treatment if symptoms develop

38
Q

post exposure prophylaxis for a child who is severely immunocompromised

A

seek specialist advice

39
Q

by which route can oseltamivir be given

A

by mouth

40
Q

how long is oseltamivir given for TREATMENT of influenza

A

BD 5 days
10 days if immunocompromised

41
Q

how long is oseltamivir given for PREVENTION of influenza

A

OD for 10 days, for up to 6 weeks
up to 12 weeks if immunocompromised

42
Q

which route can zanamivir be given via

A

inhalation of powder
iV infusion

afsha - infections (52 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions